BRIEF published on 12/11/2025 at 23:05, 5 months 30 days ago Xenetic Biosciences Adjourns 2025 Annual Stockholders Meeting Xenetic Biosciences Stockholders Meeting Voting Instructions Quorum 2025 Adjournment
PRESS RELEASE published on 12/11/2025 at 23:00, 5 months 30 days ago Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting Xenetic Biosciences, Inc. adjourns 2025 Annual Meeting of Stockholders due to lack of quorum. Stockholders urged to vote before reconvened meeting on January 8, 2026 Xenetic Biosciences Stockholders Quorum Proxy Vote 2025 Annual Meeting
BRIEF published on 11/19/2025 at 14:50, 6 months 21 days ago Xenetic Biosciences Extends Collaboration with Scripps Research Cancer Treatment Biopharmaceutical DNase I CAR-T Therapy Scripps Research
PRESS RELEASE published on 11/19/2025 at 14:45, 6 months 21 days ago Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform Xenetic Biosciences extends collaboration with Scripps Research to advance DNase-based immuno-oncology treatment for cancers Xenetic Biosciences Immuno-oncology DNase I CAR-T Therapy Scripps Research
BRIEF published on 11/13/2025 at 14:50, 6 months 27 days ago Xenetic Biosciences Reports Q3 2025 Financial Results Financial Results Revenue Increase Clinical Trials Pancreatic Carcinoma DNase Technology
PRESS RELEASE published on 11/13/2025 at 14:45, 6 months 27 days ago Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results Xenetic Biosciences, Inc. reports Q3 2025 financial results, focuses on DNase-based technology for cancer treatment. Secured $3.9 million from offering, advancing collaborations Xenetic Biosciences Cancer Treatment Collaborations DNase Technology Q3 2025 Financial Results
BRIEF published on 10/10/2025 at 15:35, 8 months ago Xenetic Biosciences Announces $4.5 Million Stock Offering Xenetic Biosciences Biopharmaceutical Immuno-oncology Stock Offering Canaccord Genuity
PRESS RELEASE published on 10/10/2025 at 15:30, 8 months ago Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock Xenetic Biosciences, Inc. announces pricing of underwritten stock offering, aiming to raise $4.5 million for immuno-oncology technologies. Canaccord Genuity acts as bookrunner Xenetic Biosciences Stock Offering Immuno-oncology Technologies Canaccord Genuity S-3 Registration Statement
BRIEF published on 08/13/2025 at 14:05, 9 months 28 days ago Xenetic Biosciences Reports Q2 2025 Financial Results Financial Results Xenetic Biosciences Q2 2025 DNase I Development Partnership Expansions
PRESS RELEASE published on 08/13/2025 at 14:00, 9 months 28 days ago Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results Xenetic Biosciences, Inc. reports Q2 2025 results, expands partnership with The Scripps Research Institute for DNase I with CAR T-cell therapies and ends quarter with $4.8M cash Financial Results Xenetic Biosciences DNase I The Scripps Research Institute CAR T-cell Therapies
Published on 06/11/2026 at 07:55, 3 hours 24 minutes ago Shelfie-Tech Provides Clarification on Private Placement
Published on 06/11/2026 at 02:45, 8 hours 34 minutes ago Drilling Completed at High-Grade Tolmer Silver Discovery
Published on 06/11/2026 at 02:35, 8 hours 44 minutes ago Panther Minerals Announces Appointment of Harrison Glancy to Board of Directors
Published on 06/11/2026 at 02:00, 9 hours 19 minutes ago Gold Basin Resources Announces Completion of Arrangement with CANEX
Published on 06/11/2026 at 11:05, 13 minutes ago Novelis Commissions First Electric Pusher Furnace at Sierre Plant
Published on 06/11/2026 at 11:05, 13 minutes ago Exyte secures three major AI-driven data center projects near Frankfurt - supporting 400 jobs in Germany
Published on 06/11/2026 at 11:05, 14 minutes ago Data-driven analyses on the future of the labor market: Stepstone expands its labor market research
Published on 06/11/2026 at 11:00, 18 minutes ago Aurubis AG: Aurubis Hamburg inaugurates world’s most powerful exhaust system in copper production
Published on 06/11/2026 at 11:00, 19 minutes ago ABB Ltd: ABB share buybacks - June 4, 2026 – June 10, 2026
Published on 06/11/2026 at 08:45, 2 hours 34 minutes ago Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/11/2026 at 08:30, 2 hours 49 minutes ago Aéroports de Paris S.A - €600 million new bond issue
Published on 06/10/2026 at 18:29, 16 hours 49 minutes ago ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026
Published on 06/10/2026 at 17:40, 17 hours 39 minutes ago Report on share repurchases from 3 to 9 June 2026
